| CASE REPORT |
|
| Year : 2020 | Volume
: 18
| Issue : 3 | Page : 245-247 |
|
|
Imatinib mesylate-induced pemphigus foliaceus in a patient with gastrointestinal stromal tumor
Priya Jeevamani Chandrasekaran1, Rohith G Chitrapur2, Murali Subramanian3, GV Vishnuvardhana4
1 Department of Dermatology, Bangalore Baptist Hospital, Bengaluru, Karnataka, India
2 Department of Haemato-Oncology, Bangalore Baptist Hospital, Bengaluru, Karnataka, India
3 Department of Medical Oncology, Bangalore Baptist Hospital, Bengaluru, Karnataka, India
4 Department of Surgical Oncology, Bangalore Baptist Hospital, Bengaluru, Karnataka, India
Correspondence Address:
Dr. Priya Jeevamani Chandrasekaran
Department of Dermatology, Bangalore Baptist Hospital, Bengaluru - 560 024, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/cmi.cmi_25_20
|
|
|
Imatinib mesylate is a tyrosine kinase inhibitor approved for treatment of gastrointestinal stromal tumors and chronic myeloid leukemia. Several cutaneous adverse reactions have been reported with its use. There are a very few reports of imatinib induced bullous disorders. We report a case of pemphigus foliaceus associated with imatinib mesylate therapy in a patient with gastrointestinal stromal tumor.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
